OTC Markets OTCPK - Delayed Quote USD

UMAX Group Corp. (UMAX)

Compare
0.0001 0.0000 (0.00%)
At close: January 23 at 7:00:00 p.m. EST
Loading Chart for UMAX
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0002 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0011
  • Volume 500
  • Avg. Volume 1,985
  • Market Cap (intraday) 7,047
  • Beta (5Y Monthly) 6.20
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.

www.umaxcorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Communication Services

Sector

Entertainment

Industry

Related News

View More

Performance Overview: UMAX

Trailing total returns as of 2025-01-24, which may include dividends or other distributions. Benchmark is

.

YTD Return

UMAX
0.00%
S&P 500
3.29%

1-Year Return

UMAX
90.91%
S&P 500
25.42%

3-Year Return

UMAX
99.89%
S&P 500
38.73%

5-Year Return

UMAX
99.92%
S&P 500
83.47%

Compare To: UMAX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UMAX

View More

Valuation Measures

Annual
As of 2025-01-24
  • Market Cap

    7.05k

  • Enterprise Value

    2.62M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -97.55%

  • Return on Equity (ttm)

    -233.54%

  • Revenue (ttm)

    13.5k

  • Net Income Avi to Common (ttm)

    -120.4k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    147.34k

  • Total Debt/Equity (mrq)

    43.23%

  • Levered Free Cash Flow (ttm)

    -69.56k

Company Insights: UMAX

People Also Watch